UFP Technologies, Inc. Aktie News

NEWBURYPORT, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that the Company plans to report results for the third quarter on Monday, November 3rd, after the close of the stock market.

The S&P 500 continues to advance to new all-time highs, delivering total returns of 15.2% so far in 2025. However, much of this run stems from the "Magnificent Seven" and other massive technology stocks that have an outsize influence on the index.

Explore the exciting world of UFP Industries (UFPT 0.02%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!

NEWBURYPORT, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (UFPT), today announced Mitch Rock, President, and Ron Lataille, Sr. VP and CFO, will present at the Midwest IDEAS Investor Conference on Tuesday, August 26, 2025, at The InterContinental in Chicago, IL. UFP's presentation is scheduled to begin at 7:55 AM CT. The presentation is webcast and can be accessed through the ...

UFP Technologies continues to deliver strong organic growth and accretive M&A, creating a defensive, diversified medtech-focused business with robust customer relationships. Recent results show impressive sales and earnings momentum, with adjusted EPS exceeding $10 annualized and leverage remaining very manageable after recent acquisitions. Valuations at 24x earnings are justified by the compan...

UFP Technologies (UFPT) Q2 EPS Jumps 27%

UFP Technologies, Inc. (NASDAQ:UFPT ) Q2 2025 Earnings Call August 5, 2025 8:30 AM ET Company Participants R. Jeffrey Bailly - CEO & Chairman Ronald J.

NEWBURYPORT, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its second quarter ended June 30, 2025, compared to net income of $13.6 million or $1.75 p...